Advertisement

Topics

Johnson Johnson caught in another scandal, forced to pay $33 million ...

01:23 EDT 23 Jun 2017 | Topix

Johnson & Johnson is set to dole out up to $33 million in settlement with 42 states over allegations that a subsidiary of the pharmaceutical drug giant sold nonprescription medicines that did not pass federal quality standards. The settlement agreement required the company to pay the amount, which would then be distributed to the District of Columbia and the 42 states that filed the case.

Original Article: Johnson Johnson caught in another scandal, forced to pay $33 million ...

NEXT ARTICLE

More From BioPortfolio on "Johnson Johnson caught in another scandal, forced to pay $33 million ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...